Press release
Connected Drug Delivery Devices Market: Transforming Healthcare with Technology-Driven Innovations
Mordor Intelligence has published a new report on the Connected Drug Delivery Devices Market, offering a comprehensive analysis of trends, growth drivers, and future projections.The connected drug delivery devices market, valued at USD 1.18 billion in 2024, is projected to grow significantly, reaching USD 5.30 billion by 2029, with a compound annual growth rate (CAGR) of 35.13% during the forecast period (2024-2029). Enhanced connectivity with smartphones and tablets has enabled more tailored and timely medical interventions. As the healthcare industry moves toward precision medicine, the demand for devices capable of delivering personalized doses is rapidly increasing.
Report Overview - https://www.mordorintelligence.com/industry-reports/connected-drug-delivery-devices-market
Key Trends: Shaping the Future of Connected Drug Delivery Devices
1. Rising Prevalence of Chronic Diseases
Chronic conditions such as diabetes, asthma, and hypertension are increasing worldwide, driving the demand for effective and efficient drug delivery systems. Connected devices provide real-time feedback and data tracking, significantly enhancing disease management.
2. Technological Advancements in IoT and AI
The integration of Internet of Things (IoT) and Artificial Intelligence (AI) technologies into drug delivery devices allows for real-time monitoring, predictive analytics, and personalized treatment. These innovations are leading to better patient outcomes and reduced healthcare costs.
3. Increasing Focus on Patient Adherence
Medication non-adherence remains a significant challenge in healthcare. Connected drug delivery devices with features like reminders, alerts, and mobile application integration help improve adherence, ensuring patients follow their prescribed regimens.
4. Growth in Telemedicine and Remote Monitoring
The COVID-19 pandemic accelerated the adoption of telemedicine, creating a supportive ecosystem for connected devices. These solutions enable remote patient monitoring and physician-patient interaction, reducing the need for frequent hospital visits.
5. Expanding Applications Across Therapeutics
Initially designed for chronic diseases, connected drug delivery devices are now being adopted across various therapeutic areas, including oncology, autoimmune disorders, and infectious diseases, broadening their market appeal.
Market Segmentation: Insights into Key Segments
The connected drug delivery devices market is segmented by product type, technology, application, and geography, offering a comprehensive analysis of the market landscape.
By Product Type:
Connected Inhalers: Dominant due to their widespread use in asthma and COPD management.
Connected Injectors: Rapidly gaining traction, especially for biologics and insulin delivery.
By Technology:
Bluetooth: Most commonly used for device connectivity.
Near-Field Communication (NFC): Gaining popularity for secure and short-range communication.
Others: Wi-Fi and mobile network integration.
By Application:
Asthma and Chronic Obstructive Pulmonary Disease (COPD): The largest application segment.
Diabetes Management: Growing adoption of connected insulin pens and pumps.
Others: Oncology, autoimmune diseases, and cardiovascular conditions.
By Geography:
North America: Leading the market due to advanced healthcare infrastructure and technology adoption.
Europe: Significant growth driven by government initiatives for digital health.
Asia-Pacific: High potential due to increasing healthcare expenditure and rising chronic disease burden.
Rest of the World: Gradual adoption with untapped opportunities.
Get a Customized Report Tailored to Your Requirements:- https://www.mordorintelligence.com/market-analysis/drug-filled-devices
Key Players: Innovators Driving Market Growth
Several key players are shaping the connected drug delivery devices market with continuous innovation, strategic partnerships, and a focus on expanding their product portfolios. Some of the prominent companies include:
Adherium Limited: A pioneer in connected inhalers, providing solutions that improve respiratory medication adherence.
Propeller Health: Offers smart inhalers integrated with mobile apps for data tracking and patient engagement.
Becton, Dickinson and Company: Focuses on connected insulin delivery systems and drug delivery pens.
Phillips-Medisize: Renowned for its expertise in developing wearable drug delivery devices.
Teva Pharmaceuticals: Leading the connected inhaler segment with its ProAir Digihaler.
These companies are investing heavily in R&D and forming collaborations with healthcare providers to enhance device functionality and expand their reach.
Conclusion: A Transformative Future for Drug Delivery
The connected drug delivery devices market is at the forefront of transforming medication management and patient care. With advancements in digital health technologies, increasing prevalence of chronic diseases, and a growing focus on personalized healthcare, the market is set to witness significant growth in the coming years.
Governments, healthcare providers, and manufacturers must collaborate to overcome challenges such as data privacy concerns and high costs. By addressing these barriers, the industry can unlock the full potential of connected drug delivery devices, paving the way for a smarter, more efficient healthcare ecosystem.
Industry Related Reports
Injectables Drug Delivery Devices Type Market: The report provides insights into the Global Injectable Drug Delivery Devices Market, highlighting market share and trends. It segments the market by device type, including Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices, by therapeutic application, encompassing Cardiovascular Diseases, Oncology, Diabetes, Autoimmune Disorders, Hepatitis, and other therapeutic applications, and by geography, covering North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/injectables-drug-delivery-devices-type-market
Implantable Drug Delivery Devices Market: The report explores trends in the Drug Infusion System Market, segmenting it by product type, including Drug Infusion Pumps, Intraocular Drug Delivery Devices, Contraceptive Drug Delivery Devices, Stents, and other products. It also categorizes the market by technology into Biodegradable Implants and Non-biodegradable Implants, and by application, covering Oncology, Cardiovascular, Autoimmune Diseases, Obstetrics and Gynecology, and other applications. Additionally, the report analyzes the market geographically across North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/implantable-drug-delivery-devices-market
UK Drug Delivery Devices Market: The United Kingdom Drug Delivery Devices Market is categorized by Route of Administration, including Injectable, Topical, and Other Routes of Administration. It is further segmented by Application, encompassing Cancer, Cardiovascular, Diabetes, Infectious Diseases, and Other Applications. Additionally, the market is divided by End-User, covering Hospitals, Ambulatory Surgical Centers, and Other End Users.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/uk-drug-delivery-devices-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Connected Drug Delivery Devices Market: Transforming Healthcare with Technology-Driven Innovations here
News-ID: 3786298 • Views: …
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…